• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性心房颤动消融的见解:6 年临床结果的启示。

Insights into ablation of persistent atrial fibrillation: Lessons from 6-year clinical outcomes.

机构信息

Department of Cardiology, Asklepios-Klinik St. Georg, Hamburg, Germany.

出版信息

J Cardiovasc Electrophysiol. 2018 Feb;29(2):257-263. doi: 10.1111/jce.13401. Epub 2018 Jan 5.

DOI:10.1111/jce.13401
PMID:29216412
Abstract

INTRODUCTION

Ablation of persistent atrial fibrillation (AF) is a potential treatment option for symptomatic patients. We sought to evaluate the critical role of circumferential pulmonary vein isolation (CPVI) in the ablation of persistent AF.

METHODS AND RESULTS

A total of 341 ablation procedures were performed in 174 consecutive patients with persistent AF. CPVI was performed in all patients, additional ablation was only performed if electrical cardioversion failed after CPVI. During a median follow-up (FU) of 89 (63; 89) months, stable sinus rhythm was documented in 42/170 (25%) patients after a single procedure and in 111/164 (68%) patients after 1.9 ± 1.1 procedures. Stable SR was achieved in 40/75 (53%) patients in whom only CPVI was performed during the index and repeat procedures and in 71/89 (79%) patients with CPVI plus additional ablation. The main predictor for ablation success was duration of persistent AF before the index procedure (P < 0.001, HR ± CI: 1.608 [1.034, 1.103]). Responders to CPVI during the initial procedure had a significantly better multiple-procedure outcome after 42 months of FU compared to CPVI nonresponders (P  =  0.0365). Conversion during the index procedure had no impact on clinical outcomes (P  =  0.0903). Persistent AF regressed to paroxysmal AF in 16% of patients.

CONCLUSIONS

We demonstrate a 25% single- and 68% multiple-procedure success in patients with persistent AF, while stable SR was achieved in 53% of patients with pure CPVI during all procedures and in 79% of patients with CPVI plus additional ablation. Only duration of persistent AF before ablation had a statistically significant impact on ablation outcome.

摘要

介绍

消融持续性心房颤动(AF)是治疗有症状患者的一种潜在治疗选择。我们旨在评估环形肺静脉隔离(CPVI)在持续性 AF 消融中的关键作用。

方法和结果

共对 174 例持续性 AF 连续患者进行了 341 次消融手术。所有患者均行 CPVI,仅在 CPVI 后电复律失败时行额外消融。在中位随访(FU)89(63;89)个月期间,单次消融后 42/170(25%)患者和 1.9±1.1 次消融后 111/164(68%)患者记录到稳定窦性节律。在索引和重复手术中仅行 CPVI 的 40/75(53%)患者和行 CPVI 加额外消融的 71/89(79%)患者中实现稳定 SR。消融成功的主要预测因素是索引手术前持续性 AF 的持续时间(P<0.001,HR ± CI:1.608[1.034,1.103])。在初始手术中对 CPVI 有反应的患者在 FU 42 个月后的多次手术结果明显优于 CPVI 无反应的患者(P=0.0365)。索引手术期间的转换对临床结果没有影响(P=0.0903)。16%的患者持续性 AF 消退为阵发性 AF。

结论

我们在持续性 AF 患者中证明了 25%的单次和 68%的多次手术成功率,而在所有手术中,仅行 CPVI 的患者中稳定 SR 的实现率为 53%,行 CPVI 加额外消融的患者为 79%。只有消融前持续性 AF 的持续时间对消融结果有统计学意义的影响。

相似文献

1
Insights into ablation of persistent atrial fibrillation: Lessons from 6-year clinical outcomes.持续性心房颤动消融的见解:6 年临床结果的启示。
J Cardiovasc Electrophysiol. 2018 Feb;29(2):257-263. doi: 10.1111/jce.13401. Epub 2018 Jan 5.
2
STABLE-SR (Electrophysiological Substrate Ablation in the Left Atrium During Sinus Rhythm) for the Treatment of Nonparoxysmal Atrial Fibrillation: A Prospective, Multicenter Randomized Clinical Trial.STABLE-SR(窦性心律时左心房电生理基质消融术)治疗非阵发性心房颤动:一项前瞻性、多中心随机临床试验。
Circ Arrhythm Electrophysiol. 2017 Nov;10(11). doi: 10.1161/CIRCEP.117.005405.
3
Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study.在采用抗心律失常药物治疗后由持续性房颤转变为阵发性房颤的患者中,单纯肺静脉隔离与附加线性消融的比较:一项多中心、前瞻性、随机研究。
Circ Arrhythm Electrophysiol. 2017 Jun;10(6). doi: 10.1161/CIRCEP.116.004915.
4
Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study.电后盒隔离在持续性心房颤动转变为阵发性心房颤动中的应用:一项多中心、前瞻性、随机研究。
Circ Arrhythm Electrophysiol. 2020 Sep;13(9):e008531. doi: 10.1161/CIRCEP.120.008531. Epub 2020 Jul 28.
5
Repeat Procedures After Hybrid Thoracoscopic Ablation in the Setting of Longstanding Persistent Atrial Fibrillation: Electrophysiological Findings and 2-Year Clinical Outcome.长期持续性心房颤动患者经胸腔镜消融术后重复手术的电生理结果及2年临床结局
J Cardiovasc Electrophysiol. 2016 Jan;27(1):41-50. doi: 10.1111/jce.12837. Epub 2015 Nov 13.
6
Does Additional Electrogram-Guided Ablation After Linear Ablation Reduce Recurrence After Catheter Ablation for Longstanding Persistent Atrial Fibrillation? A Prospective Randomized Study.线性消融术后额外的电信号引导消融能否降低长期持续性心房颤动导管消融后的复发率?一项前瞻性随机研究。
J Am Heart Assoc. 2017 Feb 7;6(2):e004811. doi: 10.1161/JAHA.116.004811.
7
Single-center experience of the FIRM technique to ablate paroxysmal and persistent atrial fibrillation.FIRM 技术消融阵发性和持续性心房颤动的单中心经验。
J Cardiovasc Electrophysiol. 2019 Apr;30(4):493-502. doi: 10.1111/jce.13832. Epub 2019 Jan 8.
8
Catheter ablation of atrial fibrillation in very young adults: a 5-year follow-up study.房颤在非常年轻的成年人中的导管消融:5 年随访研究。
Europace. 2018 Jan 1;20(1):58-64. doi: 10.1093/europace/euw378.
9
The Electrical Isolation of the Left Atrial Posterior Wall in Catheter Ablation of Persistent Atrial Fibrillation.导管消融治疗持续性心房颤动时左心房后壁的电隔离。
JACC Clin Electrophysiol. 2019 Nov;5(11):1253-1261. doi: 10.1016/j.jacep.2019.08.021. Epub 2019 Oct 30.
10
Ablation of atrial fibrillation in patients ≥75 years: long-term clinical outcome and safety.≥75 岁患者心房颤动消融:长期临床结果和安全性。
Europace. 2016 Apr;18(4):543-9. doi: 10.1093/europace/euv229. Epub 2016 Jan 29.

引用本文的文献

1
Aging-associated mechanisms of atrial fibrillation progression and their therapeutic potential.心房颤动进展的衰老相关机制及其治疗潜力。
J Cardiovasc Aging. 2024 Dec;4(4). doi: 10.20517/jca.2024.12. Epub 2024 Nov 7.
2
Artificial Intelligence in Atrial Fibrillation: From Early Detection to Precision Therapy.心房颤动中的人工智能:从早期检测到精准治疗
J Clin Med. 2025 Apr 11;14(8):2627. doi: 10.3390/jcm14082627.
3
Interleukin-6: Molecular Mechanisms and Therapeutic Perspectives in Atrial Fibrillation.白细胞介素-6:心房颤动的分子机制与治疗前景
Curr Med Sci. 2025 Apr;45(2):157-168. doi: 10.1007/s11596-025-00021-7. Epub 2025 Mar 4.
4
[Pathogenesis and potential diagnostic biomarkers of atrial fibrillation in Chinese population: a study based on bioinfor-matics].中国人群心房颤动的发病机制及潜在诊断生物标志物:一项基于生物信息学的研究
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Oct 25;53(5):593-603. doi: 10.3724/zdxbyxb-2024-0027.
5
Artificial intelligence and atrial fibrillation: A bibliometric analysis from 2013 to 2023.人工智能与心房颤动:2013年至2023年的文献计量分析
Heliyon. 2024 Jul 23;10(15):e35067. doi: 10.1016/j.heliyon.2024.e35067. eCollection 2024 Aug 15.
6
Pulmonary Vein Isolation Followed by Biatrial Ablation of Rotational Activity in Patients with Persistent Atrial Fibrillation: Results of the Cryo-Vest Study.持续性心房颤动患者肺静脉隔离后双房旋转活动消融:冷冻背心研究结果
J Clin Med. 2024 Feb 16;13(4):1118. doi: 10.3390/jcm13041118.
7
[Long-term success after catheter ablation of atrial fibrillation].[心房颤动导管消融术后的长期成功]
Herzschrittmacherther Elektrophysiol. 2023 Dec;34(4):286-290. doi: 10.1007/s00399-023-00972-1. Epub 2023 Oct 20.
8
Influence of Sex-Based Differences in Cardiac Phenotype on Atrial Fibrillation Recurrence in Patients Undergoing Pulmonary Vein Isolation.心脏表型的性别差异对接受肺静脉隔离术患者房颤复发的影响。
Front Cardiovasc Med. 2022 Jul 28;9:894592. doi: 10.3389/fcvm.2022.894592. eCollection 2022.
9
Catheter Ablation for Persistent Atrial Fibrillation in Class IV Systolic Heart Failure: A Single-Center Case Series.导管消融治疗IV级收缩性心力衰竭患者的持续性心房颤动:单中心病例系列
J Atr Fibrillation. 2021 Apr 30;13(6):20200428. doi: 10.4022/jafib.20200428. eCollection 2021 Apr-May.
10
Atrial Fibrillation (Part 2) - Catheter Ablation.心房颤动(第二部分)-导管消融。
Arq Bras Cardiol. 2021 Feb;116(2):334-343. doi: 10.36660/abc.20200477.